Characterizing the Mutational Landscape of In‐Transit Melanoma Metastases
Pigment Cell & Melanoma Research · 2026-07 · 39 (4)
DOI: 10.1111/pcmr.70112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, online erschienen am 14.07.2026. Verfasst von Luisa Quesada Camacho und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Melanoma, Mutation, Skin Neoplasms. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
In‐transit melanoma (ITM) is a unique presentation of metastatic cutaneous melanoma associated with therapeutic challenges. Despite its clinical importance, the molecular drivers of ITM remain poorly defined. We aimed to characterize the mutational landscape of ITM and identify genetic alterations distinguishing it from other melanoma metastases. Tumor samples from 528 patients in the MSK‐IMPACT dataset, comprised of over 300 cancer‐related genes, were analyzed. Samples were classified as primary, in‐transit, regional lymph node, or distant metastases. Driver mutation frequencies were compared across groups, and mutual information (MI) and principal component analysis (PCA) were used to identify ITM‐associated genes and mutation patterns. NRAS Q61 mutations were enriched in ITM compared with other melanoma sites, while NF1 mutations were less common. Exploratory MI, PCA, and pairwise analyses identified recurrent NRAS MUT /wild‐type gene patterns that may distinguish ITM from other melanoma samples. Genes retained in the wild‐type state alongside NRAS MUT were associated with PI3K/AKT/mTOR, TGF‐β, and E2F‐related pathways. Collectively, these findings suggest that ITM is enriched for NRAS Q61 mutations and may have a comparatively lower co‐mutation burden, providing a basis for future studies of ITM biology and clinical behavior.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA.
- Department of Surgery, University of Virginia, Charlottesville, Virginia, USA.
- UVA Comprehensive Cancer Center, University of Virginia, Charlottesville, Virginia, USA.
ORCID-Profile: Mackenzie M Mayhew, Nidhi Kuchimanchi, Kaelyn C Cummins
Förderung
- NCI NIH HHS
- NIH HHS
- NCATS NIH HHS
- National Institutes of Health
- National Cancer Institute
- National Center for Advancing Translational Sciences
Zitieren
APA
Camacho, L. Q., El Moheb, M., Mayhew, M. M., Mercante, M. G., Tocco, E. G., Kuchimanchi, N., Kim, S. J., Cummins, K. C., Dengel, L. T., Tsung, A., Slingluff, C. L., Fallahi-Sichani, M., & Witt, R. G. (2026). Characterizing the Mutational Landscape of In‐Transit Melanoma Metastases. Pigment Cell & Melanoma Research, 39(4). https://doi.org/10.1111/pcmr.70112
Vancouver
Camacho LQ, El Moheb M, Mayhew MM, Mercante MG, Tocco EG, Kuchimanchi N, et al. Characterizing the Mutational Landscape of In‐Transit Melanoma Metastases. Pigment Cell & Melanoma Research. 2026;39(4). doi:10.1111/pcmr.70112
BibTeX
@article{Camacho2026,
author = {Camacho, Luisa Quesada and El Moheb, Mohamad and Mayhew, Mackenzie M and Mercante, Margaret G and Tocco, Emily G and Kuchimanchi, Nidhi and Kim, Susan J and Cummins, Kaelyn C and Dengel, Lynn T and Tsung, Allan and Slingluff, Craig L and Fallahi-Sichani, Mohammad and Witt, Russell G},
title = {Characterizing the Mutational Landscape of In‐Transit Melanoma Metastases},
journal = {Pigment Cell & Melanoma Research},
year = {2026},
volume = {39},
number = {4},
doi = {10.1111/pcmr.70112}
}
EUVIMED